Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment) (HTG619)Product type:GuidanceProgramme:HealthTech guidancePublished: 30 March 2022
Prognostic tests for multiple myelomaStatus:Awaiting developmentProgramme:HealthTech guidanceExpected publication date: TBC